Board Member
Sera Prognostics, Inc. (SERA)Equibles does not estimate personal net worth.
Get an email with a short summary when Sera Prognostics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SERA alertsZhenya Lindgardt is recorded as Board Member at Sera Prognostics, Inc. (SERA) since January 1, 2021 and CEO at Sera Prognostics, Inc. (SERA). The newest filing on record that lists Zhenya Lindgardt as CEO and Board Member at Sera Prognostics, Inc. (SERA) is dated April 24, 2026. Sera Prognostics, Inc. reported in an 8-K filed May 16, 2023 that Zhenya Lindgardt was appointed Interim Chief Executive Officer, effective June 8, 2023. The proxy statement of Sera Prognostics, Inc. reports total compensation of $2,033,811 for Zhenya Lindgardt in fiscal 2025, including a base salary of $607,000. Disclosed compensation is on record for 4 fiscal years. Zhenya Lindgardt has spoken on 4 earnings calls across 1 company, most recently for Sera Prognostics, Inc. on May 7, 2025. Sera Prognostics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Sera Prognostics, Inc. includes Kim Kamdar, Ph.D. (Chairman), Austin Aerts (CFO), Scott Gleason (CFO) and 7 others.
“Concurrently with Dr. Critchfield’s retirement, Zhenya Lindgardt, a member of the Board, was appointed as the Interim Chief Executive Officer of the Company, effective June 8, 2023.”
“It's been just a few short weeks since we last held our quarterly earnings call near the end of March, during which we shared a lot of updates regarding prime and commercial priorities.”
“We're pleased with our progress last year and during the fourth quarter in laying out the foundation for future growth through key advancements in our PRIME and AVERT studies and product pipeline, all while controlling operating costs to ensure such growth is well-funded.”
“Since our last quarterly call, we’ve continued to evaluate the best means to pursue near-term revenue and position the company for long-term success, all the while being vigilant over controlling our costs and preserving a solid balance sheet, which is free of debt, and we believe comprises sufficient cash to generate…”
“Having served on Sera’s Board of Directors since November 2021 and now just a few weeks into my role as Interim President and CEO, I have developed an even greater appreciation of the company’s technology and talented employees these past few weeks.”
2021-01-01–present
Last confirmed April 24, 2026
Start not stated–present
Last confirmed April 24, 2026
Medical Devices · Healthcare
CEO, Board Member
2021-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sera Prognostics, Inc. (SERA) | President and Chief Executive Officer | $607,000 | $2,033,811 |
| 2024 | Sera Prognostics, Inc. (SERA) | President and Chief Executive Officer | $447,257 | $693,398 |
| 2023 | Sera Prognostics, Inc. (SERA) | President and Chief Executive Officer | $302,954 | $2,196,283 |
| 2022 | Sera Prognostics, Inc. (SERA) | President and Chief Executive Officer | — | $157,500 |
